Reportable Segment and Major Customers Information (Tables)

9 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Information

Segment information for the interim periods is as follows:

	Diagnostics		Life Science		Eliminations(1)			Total
Three Months Ended June 30, 2017
Net revenues -
Third-party	$	35,949	$	14,191	$	—		$	50,140
Inter-segment		71		129		(200	)		—
Operating income (2)		914		3,388		2			4,304
Goodwill (June 30, 2017)		35,213		19,399		—			54,612
Other intangible assets, net (June 30, 2017)		25,745		1,847		—			27,592
Total assets (June 30, 2017)		177,789		67,294		60			245,143
Three Months Ended June 30, 2016
Net revenues -
Third-party	$	37,523	$	13,142	$	—		$	50,665
Inter-segment		70		201		(271	)		—
Operating income		9,886		3,696		159			13,741
Goodwill (September 30, 2016)		42,608		19,374		—			61,982
Other intangible assets, net (September 30, 2016)		27,534		2,321		—			29,855
Total assets (September 30, 2016)		185,241		66,624		(42	)		251,823
Nine Months Ended June 30, 2017
Net revenues -
Third-party	$	107,529	$	43,545	$	—		$	151,074
Inter-segment		278		361		(639	)		—
Operating income (2)		17,152		11,226		197			28,575
Nine Months Ended June 30, 2016
Net revenues -
Third-party	$	110,178	$	38,906	$	—		$	149,084
Inter-segment		225		955		(1,180	)		—
Operating income		31,412		11,086		(15	)		42,483

(1) Eliminations consist of inter-segment transactions.

(2) Diagnostics’ operating income includes effect of the Magellan goodwill impairment charge in the amount of $6,628 during the three and nine month periods ended June 30, 2017.